Use of quisqualate receptor antagonists

US6191132A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Thomas Klockgether · Gomaringen, DE
• Peter-Andreas Loschmann · Berlin, DE
• David N. Stephens · Berlin, DE
• Lechoslaw Turski · Berlin, DE
• Helmut Wachtel · Berlin, DE

Key dates

• Filing date: Nov 4, 1993
• Grant date: Feb 20, 2001
• Expiry date: Nov 4, 2013

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The new use of antagonists of the AMPA receptor complex and its physiologically compatible salts as pharmaceutical agents for prevention and treatment of Parkinson's disease as well as pharmaceutical agents, which contain these compounds, is described.